FDA Approved: ATTRUBY — Original Application (BridgeBio Pharma, Inc.)

View source ↗

Summary

The FDA approved ATTRUBY (acoramidis hydrochloride) from BridgeBio Pharma as a new treatment for transthyretin amyloid cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• ATTRUBY (Acoramidis hydrochloride)

Snippet

ORIG AP for ATTRUBY (ACORAMIDIS HYDROCHLORIDE)